In the early, online edition of the Proceedings of the National Academy of Sciences, researchers from the Universities of Virginia and Massachusetts present a strategy for reactivating MECP2 — the X-linked gene that undergoes loss-of-function mutation in the neurodevelopmental condition called Rett syndrome — from the inactive X chromosome in human cell lines and mouse models.